tiprankstipranks
Trending News
More News >
XBiotech (XBIT)
NASDAQ:XBIT
US Market

XBiotech (XBIT) Income Statement

Compare
341 Followers

XBiotech Income Statement

Last quarter (Q3 2025), XBiotech's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, XBiotech's net income was $-6.01M. See XBiotech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 4.01M$ 18.39M$ 44.00M
Gross Profit
$ 0.00$ 0.00$ 3.36M$ 12.57M$ 9.45M
Operating Expenses
$ 42.47M$ 37.51M$ 37.85M$ 37.66M$ 27.73M
Depreciation and Amortization
$ 1.75M$ 1.74M$ 2.61M$ 2.65M$ 2.24M
EBITDA
$ -36.01M$ -22.57M$ -31.88M$ -22.43M$ -16.04M
Operating Income
$ -42.47M$ -37.51M$ -34.49M$ -25.08M$ -18.28M
Other Income/Expenses
$ 3.91M$ 13.20M$ 902.00K$ -376.00K$ 5.45M
Pretax Income
$ -38.56M$ -24.31M$ -33.59M$ -25.46M$ -12.83M
Net Income
$ -38.53M$ -24.56M$ -32.90M$ -17.41M$ -11.22M
Per Share Metrics
Basic EPS
$ -1.26$ -0.81$ -1.08$ -0.58$ -0.36
Diluted EPS
$ -1.26$ -0.81$ -1.08$ -0.58$ -0.36
Weighted Average Shares Outstanding
30.46M 30.32M 30.44M 30.04M 30.82M
Weighted Average Shares Outstanding (Diluted)
30.46M 30.44M 30.44M 30.04M 30.82M
Currency in USD

XBiotech Earnings and Revenue History